Polivy (polatuzumab vedotin) – most common side effects and how often they occur
| Side effect | Approx. frequency in the pivotal clinical trial (Polatuzumab + B‑R vs B‑R) | Notes |
|-------------|---------------------------------------------------------------------|-------|
| Nausea | 50–60 % (any grade) | Often mild; treat with anti‑emetics |
| Fatigue | 45–55 % (any grade) | Can be dose‑related |
| Neutropenia (grade ≥ 3) | 37 % (Polivy + B‑R) vs 30 % (B‑R) | Febrile neutropenia: 8 % (Polivy + B‑R) |
| Anemia (grade ≥ 3) | 27 % (Polivy + B‑R) | Often transfusion‑required |
| Thrombocytopenia (grade ≥ 3) | 20 % (Polivy + B‑R) | Monitor platelet counts |
| Peripheral neuropathy (grade ≥ 2) | 15–20 % (Polivy + B‑R) | Usually reversible |
| Infusion‑related reactions | 4 % (any grade) | Treated with pre‑medication and pause |
| Diarrhea | 20–30 % (any grade) | Manage with loperamide if needed |
| Vomiting | 25–35 % (any grade) | Antiemetic prophylaxis recommended |
| Headache | 15 % (any grade) | Usually mild to moderate |
How to interpret these numbers
- Percentages are from the pooled analysis of the Phase III trial that led to FDA approval (Polatuzumab + B‑R vs. B‑R alone).
- The “any grade” column includes all severity levels; the “grade ≥ 3” column lists serious events that most often require dose modification or treatment interruption.
- About 80 %–90 % of patients on Polivy experience at least one adverse event, but most are manageable with supportive care.
Quick take‑away
- Neutropenia, anemia, and thrombocytopenia are the most frequent serious side effects and are monitored closely.
- Nausea, fatigue, and GI symptoms occur in roughly half of patients but are usually mild to moderate.
- Peripheral neuropathy and infusion reactions are less common but should be watched for, especially in patients with pre‑existing neuropathy.
---
Bottom line
If you’re being considered for Polivy, your oncology team will monitor blood counts and neuropathy closely, and will give anti‑emetics and growth factors as needed. Talk to your doctor about any concerns—especially if you have a history of blood disorders or neuropathies.